Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | ELANE | P08246 | 2/20 | 0.44 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25689307 | 1.00 | ALDH1A1 (0.47) | ALDH1A1MAPTMAPK1KMT2ACYP2C19 | |
| SCHEMBL25689300 | 1.00 | ALDH1A1 (0.47) | ALDH1A1MAPTMAPK1KMT2ACYP2C19 | |
| SCHEMBL27590251 | 1.00 | ALDH1A1 (0.47) | ALDH1A1MAPTMAPK1KMT2ACYP2C19 | |
| SCHEMBL27675584 | 1.00 | ALDH1A1 (0.47) | ALDH1A1MAPTMAPK1KMT2ACYP2C19 | |
| SCHEMBL14449391 | 1.00 | ALDH1A1 (0.47) | ALDH1A1MAPTMAPK1KMT2ACYP2C19 | |
| SCHEMBL3503753 | 1.00 | ALDH1A1 (0.47) | ALDH1A1MAPTMAPK1KMT2ACYP2C19 | |
| SCHEMBL2126891 | 0.88 | MAPT (0.50) | ALDH1A1MAPTMAPK1KMT2ACYP2C19 | |
| SCHEMBL28249395 | 0.84 | MAPT (0.47) | ALDH1A1MAPTMAPK1KMT2ACYP2C19 | |
| Benzaldehyde SCHEMBL28051518 | 0.84 | CYP2C19 (0.58) | ALDH1A1MAPTMAPK1KMT2ACYP2C19 | |
| SCHEMBL2134324 | 0.83 | ALDH1A1 (0.46) | ALDH1A1MAPTMAPK1KMT2ACYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 407 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4216955-B1 | ORAL COMPOSITIONS COMPRISING ANTAGONISTS THAT INHIBIT OR BLOCK NICOTINIC ACETYLCHOLINE RECEPTORS (NACHR) AND/OR TRANSIENTRECEPTOR POTENTIAL (TRP) ION CHANNELS FOR NICOTINE BURNING RELIEF | FERTIN PHARMA AS (DK) | 2026-04-08 | — | — | EP | claimed |
| US-20250212873-A1 | VOLATILE HDAC INHIBITORS FOR THERAPEUTIC AND PLANT APPLICATIONS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2025-07-03 | — | — | US | claimed |
| US-20250082004-A1 | INHIBITION OF SENSORY IRRITATION DURING CONSUMPTION OF NON-SMOKEABLE TOBACCO PRODUCTS | PHILIP MORRIS USA INC. (US) | 2025-03-13 | — | — | US | claimed |
| EP-4482306-A1 | VOLATILE HDAC INHIBITORS FOR THERAPEUTIC AND PLANT APPLICATIONS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2025-01-01 | — | — | EP | claimed |
| US-12161145-B2 | Inhibition of sensory irritation during consumption of non-smokeable tobacco products | PHILIP MORRIS USA INC. (US) | 2024-12-10 | — | — | US | claimed |
| CN-113789224-B | Preparation and application of Jin Maoer grass volatile oil | 山东智汇达海洋生物科技有限公司 | 2024-03-01 | — | — | CN | claimed |
| WO-2023192424-A1 | VOLATILE HD AC INHIBITORS FOR THERAPEUTIC AND PLANT APPLICATIONS CROSS-REFERENCE TO RELATED APPLICATION | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2023-10-05 | — | — | WO | claimed |
| EP-4216955-A1 | ORAL ANTAGONIST COMPOSITIONS FOR NICOTINE BURNING RELIEF | Fertin Pharma A/S (DK) | 2023-08-02 | — | — | EP | claimed |
| US-20230174457-A1 | INSECT REPELLENT COMPOUNDS AND COMPOSITIONS, AND METHODS THEREOF | UNIV IOWA STATE RES FOUND INC (US) | 2023-06-08 | — | — | US | claimed |
| CN-116194106-A | Oral antagonist composition for nicotine burn relief | 费尔廷制药公司 | 2023-05-30 | — | — | CN | claimed |
| WO-2014146069-A1 | INHIBITION OF CENTRAL NERVOUS SYSTEM EFFECTS FROM SMOKING AND SENSORY EFFECTS FROM SMOKING | Altria Client Services Inc. (US) | 2014-09-18 | — | — | WO | claimed |
| US-8609600-B2 | Encapsulation of bulky fragrance molecules | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2013-12-17 | — | — | US | claimed |
| US-8603963-B1 | Fragrance compositions containing low vapor pressure VOC solvents | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2013-12-10 | — | — | US | claimed |
| EP-2552245-A2 | INHIBITION OF SENSORY IRRITATION DURING CONSUMPTION OF NON-SMOKEABLE TOBACCO PRODUCTS | Philip Morris Products S.A. (CH) | 2013-02-06 | — | — | EP | claimed |
| US-20120247492-A1 | INHIBITION OF SENSORY IRRITATION DURING CONSUMPTION OF NON-SMOKEABLE TOBACCO PRODUCTS | PHILIP MORRIS USA INC. (US) | 2012-10-04 | — | — | US | claimed |
| WO-2011117740-A2 | INHIBITION OF SENSORY IRRITATION DURING CONSUMPTION OF NON-SMOKEABLE TOBACCO PRODUCTS | PHILIP MORRIS PRODUCTS S.A. (CH) | 2011-09-29 | — | — | WO | claimed |
| WO-2009131692-A1 | SUBSTRATES FOR DELIVERY OF PHYSIOLOGICALLY ACTIVE AGENTS | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ALABAMA (US) | 2009-10-29 | — | — | WO | claimed |
| WO-2004107859-A2 | NOVEL HERBAL MOSQUITO REPELLENT COMPOSITIONS | IYER GANESH NATRAJAN (IN) | 2004-12-16 | — | — | WO | claimed |
| US-20040223998-A1 | Insect repellent | IYER GANESH NATRAJAN (IN) | 2004-11-11 | — | — | US | claimed |
| EP-1046082-B1 | METHOD FOR DEVELOPMENT OF PHOTOPOLYMER PRINTING PLATES | NUPRO TECHNOLOGIES INC (US) | 2004-05-19 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040223998-A1 | Insect repellent | LSS, BCHE, L3MBTL4 | ALDH1A1 4071/4885MAPT 926/4885MAPK1 2737/4885 |
| US-20230174457-A1 | INSECT REPELLENT COMPOUNDS AND COMPOSITIONS, AND METHODS THEREOF | C5, CYP51A1, DDT | ALDH1A1 2604/4885MAPT 1512/4885MAPK1 2411/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.